GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hansen Medical Inc (NAS:HNSN) » Definitions » Total Revenue Growth Rate (Future 3Y To 5Y Est)

Hansen Medical (Hansen Medical) Total Revenue Growth Rate (Future 3Y To 5Y Est) : N/A (As of May. 22, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Hansen Medical Total Revenue Growth Rate (Future 3Y To 5Y Est)?

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period.

As of today, Hansen Medical's Total Revenue Growth Rate (Future 3Y To 5Y Est) is N/A.


Competitive Comparison of Hansen Medical's Total Revenue Growth Rate (Future 3Y To 5Y Est)

For the Medical Instruments & Supplies subindustry, Hansen Medical's Total Revenue Growth Rate (Future 3Y To 5Y Est), along with its competitors' market caps and Total Revenue Growth Rate (Future 3Y To 5Y Est) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hansen Medical's Total Revenue Growth Rate (Future 3Y To 5Y Est) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hansen Medical's Total Revenue Growth Rate (Future 3Y To 5Y Est) distribution charts can be found below:

* The bar in red indicates where Hansen Medical's Total Revenue Growth Rate (Future 3Y To 5Y Est) falls into.



Hansen Medical  (NAS:HNSN) Total Revenue Growth Rate (Future 3Y To 5Y Est) Explanation

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.

In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.


Hansen Medical Total Revenue Growth Rate (Future 3Y To 5Y Est) Related Terms

Thank you for viewing the detailed overview of Hansen Medical's Total Revenue Growth Rate (Future 3Y To 5Y Est) provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansen Medical (Hansen Medical) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Hansen Medical Inc, formerly known as AutoCath Inc, was incorporated in Delaware in 2002. The Company completed its initial public offering on February 28, 2014. The Company develops, manufactures and sells medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies. Its products include Sensei Robotic Catheter System, Magellan Robotic System, Artisan catheter, Lynx catheter, Magellan Robotic Catheter, and CoHesion 3D Visualization Module. Sensei Robotic Catheter System, or Sensei system, is designed to allow physicians to navigate flexible catheters with solid stability and control in interventional procedures within the atrial heart chambers. This system enables physicians to direct the movements of a robotic catheter like the Company's Artisan Control Catheter and Artisan Extend Control Catheter, or Artisan catheters, and Lynx Robotic Ablation Catheter, or Lynx catheter, to an anatomical location. The Sensei system is comprised of two modules: a physician control console and a patient-side module that can be connected to procedure tables. The control console can be located inside the Electro-Physiology Laboratory, or EP lab, and close to the patient or outside the EP lab in a separate location shielded from radiation. The Company's Magellan Robotic System is a peripheral vascular interventional platform that, used in combination with the Magellan Robotic Catheters, has the potential to provide endovascular specialists with vessel navigation, catheter stability during the manual delivery and placement of therapeutic devices, reduced procedural radiation exposure and fatigue, and precise robotic control of distal catheter tips. Magellan Robotic System is comprised of two modules: a physician control console and a patient-side robotic arm that can be connected to procedure tables. The Artisan catheter is a disposable catheter and guide catheter assembly that consists of a telescoping set of control catheters that are integrated to provide the desired motion of the tip of a diagnostic or therapeutic catheter that is inserted through the center lumen of the Artisan catheter. This is designed to accurately control the movement of a third party catheter chosen by the physician. CoHesion 3D Visualization Module, or CoHesion Module, is a software interface between Sensei system and the St. Jude Medical EnSite System for EP procedures. It is designed to provide physicians with 3D visualization to augment their ability to move a catheter throughout the atria, as well as increase control over placement of the catheter in specific locations. The Company markets, sells and supports its products in the United States through a direct sales force of regional sales employees, supported by clinical account managers who provide training, clinical support and other services to customers. Outside the United States, in the European Union, it uses a combination of a direct sales for
Executives
William R Rohn director PO BOX 676367, RANCHO SANTA FE CA 92067
Christopher P. Lowe director, officer: Interim CFO 2511 N LOOP 1604,, SUITE 204, SAN ANTONIO TX 78258
Oracle Institutional Partners L P 10 percent owner 200 GREENWICH AVENUE, 3RD FLOOR, GREENWICH CT 06830
Oracle Partners Lp 10 percent owner 200 GREENWICH AVE, 3RD FL, GREENWICH CT 06830
Larry N Feinberg 10 percent owner C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
Oracle Associates Llc 10 percent owner 200 GREENWICH AVENUE, 3RD FLOOR, GREENWICH CT 06830
Stephen L Newman director 13737 NOEL ROAD, SUITE 100, DALLAS TX 75093
Oracle Ten Fund Master, Lp 10 percent owner C/O ORACLE INVESTMENT MANAGEMENT, INC., 200 GREENWICH AVENUE, GREENWICH CT 06830
Jack W. Schuler Living Trust other: Former 10% Owner 100 NORTH FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Family Foundation Schuler other: Former 10% Owner 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Marjorie L. Bowen director 225 6TH STREET, MANHATTAN BEACH CA 90266
Jack W Schuler director, 10 percent owner 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Peter J Mariani officer: Chief Financial Officer C/O GUIDANT CORP, 111 MONUMENT CIRCLE #2900, INDIANAPOLIS IN 46204-5129
Bruce Barclay director
Russell C Hirsch director 435 TASSO STREET, SUITE 200, PALO ALTO CA 94301